Driscoll one of 40 hospitals nationwide participating in Pfizer trial for COVID-19 vaccine for children younger than 12

Translate to Spanish or other 102 languages!

Iris Gutierrez (from left), Sophia Gutierrez, 10, Pediatrician Valeria Munguia Jovel, MD, Erin Richmond, MS, RN, CCRP, Program Manager, Global Institute for Hispanic Health, and Jaime Fergie, MD, Director of Infectious Diseases at Driscoll Children’s Hospital and Medical Director of Driscoll’s and Texas A&M University’s Global Institute for Hispanic Health.

Mega Doctor News

- Advertisement -

CORPUS CHRISTI – Driscoll Children’s Hospital is one of 40 hospitals nationwide and 100 hospitals worldwide participating in a Pfizer clinical trial for a COVID-19 vaccine for children younger than 12. Driscoll is the only clinical trial site for South Texas.

The first participant, Sophia Gutierrez, 10, of Odem, was at Driscoll on Monday undergoing the necessary labwork and receiving her first shot.

“I really wanted to get vaccinated so I could see my grandmother and other family members,” said Sophia.

- Advertisement -

The clinical trial is open for children six months to 11 years. Driscoll Children’s Hospital and Texas A&M University’s Global Institute for Hispanic Heath are conducting the trial, but participants do not have to be Hispanic or Driscoll patients.

“The Global Institute for Hispanic Health strives to bring important clinical studies to our region. We are happy to be able to offer this COVID-19 trial to the children of South Texas,” said Jaime Fergie, MD, Director of Infectious Diseases at Driscoll Children’s Hospital and Medical Director of Driscoll’s and Texas A&M University’s Global Institute for Hispanic Health.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Preventing Carbon Monoxide Exposure

Mega Doctor News CLEVELAND CLINIC - With cooler weather here to stay and...

STHS Heart Ranked Among Texas’ Top 5 Hospitals for Coronary Intervention

For Valley residents, STHS Heart continues to distinguish itself through nationally recognized heart and vascular services and a commitment to delivering high-quality, compassionate care close to home.

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Mount Sinai Trial Improves Coronary Stent Expansion

A randomized clinical trial at The Mount Sinai Hospital found that combining two techniques for removing calcium nodules—rotational atherectomy and intravascular lithotripsy (IVL)—before coronary stent placement allowed stents to expand more fully than IVL alone in patients with calcified coronary nodules.  
- Advertisement -